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Abstract
Managing clinical trials, of whatever size and complexity, requires efficient trial management. Trials fail because
tried and tested systems handed down through apprenticeships have not been documented, evaluated or pub-
lished to guide new trialists starting out in this important field. For the past three decades, trialists have invented
and reinvented the trial management wheel. We suggest that to improve the successful, timely delivery of impor-
tant clinical trials for patient benefit, it is time to produce standard trial management guidelines and develop
robust methods of evaluation.
Introduction
Over the past 50 years, eminent trialists have written
persuasively and repeatedly of the need for large, rando-
mised, controlled trials [1], and such trials are consid-
ered the highest level of evidence for guiding clinical
practice. However, how to manage these important trials
has had little mention in most commentaries. Many
clinical trials fail to deliver because of the lack of a
structured, practical, businesslike approach to trial man-
agement. The human and financial resources for con-
ducting a randomised trial is finite, so it is crucial that
every effort is made to ensure that a trial is implemen-
ted simply and managed efficiently. A randomised trial
involves a huge investment of time, money and people;
therefore, it warrants expert management and needs to
be managed from its inception like any other business.
To review the literature, develop a protocol, apply for
funding and design data collection forms requires
lengthy consultations and a considered approach. Rarely
is this essential depth of thinking applied to how the
trial will actually be managed. Trial management is
essential amongst the key competencies that are needed
to deliver high-quality trials. It is recognised that well
designed trials are the basis for addressing important
clinical questions, but science alone will not be sufficient
to successfully deliver a trial. Once the science is deter-
mined and the trial acceptedt h r o u g ht h ep e e rr e v i e w
process, the challenge is quite different. The key chal-
lenge is then to establish and implement management
systems and techniques that are effective and responsive
to the needs of the trial and the trialist [2]. Clinical trials
all require the same coordinated processes and systems,
regardless of the size, scope, costs or duration.
An analysis of 114 multicentre trials funded by the
National Institute of Health Research (NIHR) Health
Technology Assessment (HTA) and UK Medical
Research Council (MRC), STEPS [3], showed that 45%
failed to reach 80% of the prespecified sample size. Less
than one third of the trials recruited their original target
number of participants within the time originally speci-
fied, and around one third had to be extended in time
and resources. One factor observed in trials that
recruited successfully was that they had employed a
dedicated trial manager (odds ratio: 3.80, 95% CI: 0.79
to 36.14; P = 0.087). The STEPS collaborators suggest
that anyone undertaking trials should think about the
different needs at different phases in the life of a trial
and put greater emphasis on ‘conduct’ (the process of
actually doing trials) [3]. In addition, the MRC acknowl-
edged that the failure of some trials can be due to prac-
tical problems with trial management rather than
scientific problems or problems with the trial design [4].
F r a n c i se ta l .[ 3 ]e x a m i n e dw h e ther clinical trials could
be considered from a business management perspective
and proposed that the dimensions of running a success-
ful trial includes ‘marketing’, ‘sales’ and ‘ongoing client
management’. They recognised that in the recruitment
stage of a randomised controlled trial (RCT), the most
demanding activity is to establish and implement a
range of effective management techniques which parallel
those used to run a successful business.
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Prescott et al. [5] assembled and classified a comprehen-
sive bibliography of factors limiting the quality, number
and progress of RCTs. They identified barriers to clinician
participation that included, for example, time constraints,
concern about the impact on doctor-patient relationships,
concern for patients, lack of reward and recognition, and
an insufficiently interesting question. Barriers to patient
participation included issues such as additional demands
of the trial, patient preferences, concern caused by uncer-
tainty and concerns about information and consent. They
recommended that to overcome barriers to participation, a
trial should address an important research question and
the protocol and data collection should be as straightfor-
ward as possible, with demands on clinicians and partici-
pants kept to a minimum. Dedicated research staff may be
required to support clinical staff and participants. The
recruitment processes of an RCT should be carefully
planned and piloted regardless of size or complexity.
On the basis of experience in noncommercial aca-
demic initiated trials, Farrell and Kenyon [6] in The
Guide to Efficient Trial Management suggest that
actively managing every aspect of the trial is key to suc-
cess. If clinicians are to recruit participants, they should
feel comfortable and trained in trial processes and pro-
cedures. This can be achieved using a variety of meth-
ods: one-to-one training, group work, distance learning
methods (videos via the web and teleconferences).
National and international presentations and discussions
to continually highlight the importance of the trial must
be organised by the trial team. Maintaining a personal
interface with a collaborative group of clinicians,
whether this is a group of 7 or 700, is probably the
biggest challenge for a trial manager and the trial team
but one that will result in a more cohesive trial.
A trial manager
The importance of a trial manager to the success of the
project is recognised by the NIHR HTA programme, and
they recommend that all primary research projects appoint
a dedicated project/trial manager. Ideally, trial managers
should be involved early on in the trial design phase, but
this is rarely possible because of funding constraints. How-
ever, a good trial manager involved in the trial design and
funding application will make a valuable contribution to
the practicalities of conducting the trial, potentially saving
money and avoiding unworkable systems. Generic job
descriptions produced by the HTA [7] and the UK Trial
Managers’ Network (UKTMN) [8] identify the key respon-
sibilities of a trial manager as follows:
￿ Having a leading role in planning, coordinating and
completing a project
￿ Excellent communication and presentation skills
￿ The ability to organise and motivate others
￿ Flair, enthusiasm, innovation and leadership when
faced with challenges
￿ The ability to manage the trial budget(s) and main-
tain the accounts
￿ Having strategic, tactical and operational manage-
ment skills in the planning and execution of a project
Despite the complex responsibilities of this role, the
body of knowledge available to guide trial managers is
very limited. In 1998, Farrell [9] described the need for
trial management models and methodology to be estab-
lished, recognised and published to provide a body of evi-
dence for those undertaking clinical trials, large or small;
yet more than 10 years on very little recognised reference
material, other than The Guide to Efficient Trial Manage-
ment [6], is readily available. In addition to a trial man-
ager, an efficient, well-trained trial management team
can be the deciding factor in the success or failure of a
trial. The trial team will be decided by the needs of the
trial itself and, apart from the Chief Investigator, it
should include a trial manager, a trial statistician, a trial
programmer, a data manager, data clerks, administrative
staff and other trial specific staff, e.g., health economists.
Each of these has an important role to play, and clarity
about exactly what each of the roles involves is crucial if
every aspect of a trial is to be managed well; it requires a
team effort. In the UK, the recent development of
research networks and the registration of Clinical Trials
Units has seen the ‘portfolio trial manager’ emerge. The
portfolio manager has to deal with a variety of tasks
across a range of trials which can present different chal-
lenges. The success or failure of this approach will
become apparent over the coming decade.
Project planning
A clinical trial shares many features with any other type
of business project as defined in the field of project
management [10]. These features include the following:
￿ A clear objective aimed to bring about change
￿ Requiring a team
￿ A set time scale
￿ Defined resources to achieve its objective
￿ Tasks which need to be completed (to a prespeci-
fied standard)
All projects consist of a series of processes, a set of
actions to bring about results. The five basic process
stages are [10]:
1. Initiating
2. Planning
3. Executing
4. Monitoring and controlling
5. Analysis and reporting
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fore, developing a management plan is key for effective
trial management. It is essential that a project manage-
ment plan include details of the arrangements for devel-
oping and monitoring all aspects of a trial, including
servicing the steering committee and the independent
data monitoring committee but, most important, how the
day-to-day running of the trial will be planned and mana-
ged. The development of a robust statistical analysis plan
supported with sufficient resources and time to conclude
the trial efficiently is a crucial element of this plan. The
project plan should also describe who will be responsible
for essential activities, such as staff recruitment, staff
management, communication with the collaborative
group, recruitment monitoring, data management, and
raising project awareness (promotion), through to safety
reporting, analysis, report writing and dissemination of
the trial results. The project plan should describe what
the trialists are trying to achieve, how resources will be
used and within what time frame. It should also include
how the planned processes will be monitored to ensure
that the project is being delivered as planned. The plan
can then be reviewed and refined, if necessary, as the trial
progresses. Clear processes, both inside and outside the
office, need to be established and documented. The abil-
ity to constantly review and adapt the project plan is cru-
cial as a trial can be hit side-on by events outside its
control, e.g., emerging evidence, war leading to lack of
recruitment and natural disasters. Sensible risk assess-
ment, tailored quality assurance management systems
and real-time monitoring are essential if a trial is to opti-
mise its potential and provide reliable evidence.
The Clinical Trial Toolkit [11] was developed in 2003
to coincide with the implementation of the EU Clinical
Trials Directive [12] by the UK Medical Research Coun-
cil (MRC) and the UK Department of Health as a tool
to guide people embarking on a clinical trial through
the regulatory and governance requirements. The toolkit
is a good starting point for trialists and trial managers
to ensure all legal obligations are met, but it does not
specify how to run a trial.
Collaboration
Good evidence that the clinical question being evaluated
is in equipoise is important, but it is only part of the
equation. The question also needs to be relevant to clin-
icians and nurses as they are likely to be the people
recruiting the participants. To be successful, most trials
depend on developing some sort of collaborative group.
The aim of a collaborative group or network is to be
inclusive rather than exclusive. Proactively raising the
profile of any developing project and creating a group of
interested people takes time and commitment. This can
be done in many ways, through personal contact,
presentations at relevant conferences, mailshots, news-
letters from the professional colleges, journal articles
and general word of mouth. The success of a trial, parti-
cularly recruitment, may require thinking ‘outside the
box’ and training, supporting and crediting other groups
who are not traditionally directly involved in the
research process but nevertheless are crucial to a trial:
for example, nurses, records department staff, ward
clerks, radiology staff. A trial is likely to be more suc-
cessful, and enjoyable, if members of the collaborative
group feel they ‘own’ the project. This ownership will be
fostered by involvement and consultation at every stage,
from protocol development to publication of the results.
All trials need to be actively promoted or marketed.
Part of this strategy will be a memorable name and/or
identifiable logo and a thoroughly professional image. It
is well established that interdisciplinary collaboration
offers greater potential for success [13]. For large trials,
this will be a diverse multidisciplinary group including
representatives from each participating site. For smaller
and single-centre studies, the group will be less formal
and may be just a handful of like-minded people. Bam-
mer [14] identified that there is a growing body of
research on collaborations which include examinations
of the increase in collaborations and team sizes, patterns
of collaborative networks, motives, choices and strate-
gies for collaboration, the measurement of collaboration,
how collaborations are organised and how successful
collaborations are measured. However, how these con-
cepts are applied to trial management is unclear, and
further observation and evaluation are necessary but dif-
ficult to carry out. The only reliable way to obtain good
evidence that business concepts work in a clinical trial
would be to conduct a randomised trial. One half of the
trial would be managed according to a project plan and
the other half left to run without a plan; we suspect this
would be unacceptable to any funder and certainly
unacceptable to a good trial team. Some elements of
trial management may be easier to evaluate, such as the
best method of ensuring data are completed and
returned, but once again this carries an element of risk
(as does any trial) and will have resource implications.
Minimal work for investigators and participants
Minimal work for investigators and participants means
ensuring recruitment procedures run alongside routine
practices. Site visits and talking to staff in the place
where recruitment happens will make sure recruitment
to the trial becomes part of the daily routine. The
recruitment procedure needs to be realistic and practi-
cal; for example, web randomisation may not be practi-
cal for a trial being conducted in an Intensive Care Unit
or in a trial of an emergency intervention. Clinical staff
a r ea l w a y sb u s ya n dm a yb er e l u c t a n tt oc a r r yo u t
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procedures and extra tests or visits may also deter the
enthusiastic participant. The data that need to be col-
lected to answer the clinical question should be readily
available to the recruiting staff.
Development of the data collection forms should
begin early in the process of trial development. Ideally,
dummy tables that reflect the final analysis would be
prepared as part of the statistical analysis plan to ensure
that the data collection forms do not collect unnecessary
data. This takes considerable discipline but will avoid
omissions in the data collection forms and minimise the
collection of data that will never be reported. Experience
has generated some simple tips for the design of data
forms such as always collect the raw data; if necessary,
it can be put into categories later. Questions should be
ordered in a way that reflects clinical progression and
makes sense to the person completing the form. Data
collected as ‘free text’ is not advisable, as this can con-
siderably increase the data management workload and
increase the risk of misinterpretation of the data, but is
nevertheless sometimes unavoidable. A recent article by
Edwards [15] provides a theoretical guideline for ques-
tionnaire design and administration but acknowledges
that further evaluation is required.
Communication
Investigators need to feel valued and part of an inclusive
team answering an important clinical question, so pro-
viding regular feedback that ensures they feel involved
must be central to a trial’s communication strategy.
Remembering the audience being addressed and tailor-
ing all communication appropriately will help busy clini-
cians identify his or her priorities and maintain trial
‘buy-in’.U s i n ga ni n v e s t i g a t o r ’s preferred method of
communication (telephone, email, letter, web site and
personal contact) will ensure he or she feels communi-
cation is personal. Projecting a positive image about trial
progress generally as well as progress within any given
site will encourage continued involvement. Listening to
problems and resolving any issues quickly will increase
confidence in the trial and the trial team. Investigators
should always be made to feel appreciated and not over
burdened by involvement in the trial.
Efficient systems
A trial, particularly a large trial, needs robust compu-
terised systems and procedures that monitor every aspect
of the day-to-day running of the trial. A reliable system
that will monitor recruitment, randomisation procedures,
stock control, data management, data cleaning, and cen-
tral data monitoring and that will produce useful reports
should be developed. Every essential piece of paper that
relates to a trial participant should be logged and tracked
through the system. There needs to be a logical and
transparent structure, concise documentation (standard
operating procedures) and accountability of every process
employed in the trial. If the trial is international, these
systems should take account of differing clinical prac-
tices, working environments and governance regulations.
Good quality data depend on effective trial manage-
ment. Collecting data by the use of a case report form
and entering it into a database are quite simple tasks.
However, ensuring that these data are sensible, reliable
and reflect the ‘true situation’ is a complicated and
detailed process. With the aid of computers, data valida-
tion and quality control can be quick and efficient, but
these systems also need to be flexible and adaptable so
that they can respond to the needs of the investigators
and the changing needs of the trial. Using systems that
reduce the number of steps required for data entry,
such as the use electronic data capture, can minimise
the workload for both investigators and the data man-
agement team. However, if trialists intend to use elec-
tronic data capture, a good deal of preparatory work
needs to go into form design and training to avoid add-
ing to the workload. Adherence to database design, test-
ing and validation standards is crucial during the
computer system development process and required
under clinical trials legislation [16].
Efficient recruitment of trial participants
A trial succeeds or fails on the basis of whether it man-
ages to recruit the prespecified number of participants
to reliably answer the question, and yet there is very lit-
tle research evidence to guide recruitment strategies.
Mapstone et al. [17] identified 15 eligible trials aimed at
recruiting participants for health care studies. Trials of
monetary incentives, an additional questionnaire at invi-
tation and treatment information on the consent form
demonstrated benefit. However, these specific interven-
tions from individual trials are not easily generalisable.
The authors concluded that on the basis of this evi-
dence, it is not possible to predict the effect most inter-
ventions will have on recruitment. A Cochrane review
on incentives and disincentives to participation by clini-
cians in RCTs by Rendell et al. [18] found 11 relevant
observational studies relating recruitment rates to a
number of factors. In particular, these studies suggested
that there was more recruitment if the clinician
￿ Was interested in evidence based practice
￿ Was participating in an academic group
￿ Had extra staff to help with recruitment
￿ Thought patients might be interested
￿ Felt comfortable about explaining trials
Although these may provide some pointers for areas
to address, the review authors concluded that the
research evidence base for strategies for increasing
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needed. Experienced trial managers, who have learnt
through apprenticeship, continually monitor, review and
revise the recruitment strategies being used, and this
body of experience has been published online as part of
The Guide to Efficient Trial Management[5]. To main-
tain recruitment at the necessary level over a long per-
iod of time, say, 3 to 5 years, requires stamina in
everyone involved in a trial. Strategies used to do this
might include visiting sites where the trial is working
well and seeing what lessons can be learnt and applying
them elsewhere. Using the experiences of individuals
within the collaboration who are doing well to teach
others, either in newsletters or at meetings, is very valu-
able and encourages internal collaboration and capacity
building. Ensuring there is always clear, professional lit-
erature regarding the trial at recruiting sites is a task
that a good trial manager will incorporate into the pro-
ject plan. If promotional material is not updated regu-
larly with new eye-catching information, it quickly
becomes just part of a sea of other information and all
impact is lost. Making sure the trial team go to meetings
prepared, i.e., knowing how sites are recruiting, the
quality of the data collection and who are the most
important people to meet to discuss the trial’s progress,
should be a ‘given’, but this is not always the case.
Publication and dissemination
How credit for the trial will be shared is also an impor-
tant component of the project development and manage-
ment plan. For collaborative trials, it is vital that
appropriate credit is given where it is due and that every-
one who has wholeheartedly contributed gains recogni-
tion in one way or another. This will often mean
publication of the results as a collaborative group. Group
authorship is a particular issue for trial managers as
under the collaborative authorship policy rarely does the
trial manager get acknowledged for their individual con-
tribution. This is a real concern for those working toward
making trial management their career pathway and those
working to promote a career structure for trial managers.
The trial will mean nothing if the results are not dis-
seminated and taken account of in clinical practice.
Results of a trial can be made widely available using a
variety of media, such as articles in medical journals,
online journals, trial registers, systematic reviews and
conference presentations. An advantage of a multicentre
trial is that each investigator, working within an agreed
policy, can be responsible for local dissemination and
presentation. Trial results should be published whatever
the outcome of the trial, and it has been described as
scientific misconduct not to publish [19]. Reporting the
results must maintain confidentiality, and it must not be
possible to identify individual participants or sites within
the report. The CONSORT Guidelines [20,21] provide a
standard for reporting clinical trials which aims to
improve the quality and transparency of trial reporting.
Education, training and experience
The EU Clinical Trials Directive 2001 [12] specifies that
every member of a trial team should have the appropriate
education, training and experience to perform his or her
tasks. For a trial manager of any trial, it is difficult to com-
ply with this regulation as specialised training in trial man-
agement does not exist and there is no recognised
qualification that can prove that a trial manager has been
educated in the discipline. Much of the collective wisdom
about doing trials has been passed on by apprenticeship,
very much a ‘suck it and see’ approach which can be to
the cost of the trial and the trial manager. For those
wishing to pursue a career in trial management, the lack
of good practice guidelines and standards can be extre-
mely challenging and at times very frustrating. A survey
undertaken by the UKTMN in 2005 identified the need
for courses in practical management of clinical trials. Of
the 284 trial managers surveyed, 60% were not seeking
higher education qualifications but wanted flexible, acces-
sible, specific training relevant to their jobs. For those who
do want to study for a higher qualification, the distance
learning MSc/Post Graduate Diploma in Clinical Trials by
Distance Learning [22] has been developed by the London
School of Hygiene and Tropical Medicine and the Univer-
sity of London. The MSc includes project management
principles as one of the fundamentals of trial conduct.
Many other courses and workshops on clinical trials also
include an element of project management skills training.
However, although intuitively trial managers are utilising
these skills, more evidence is needed to support the appli-
cation of project management principles and practices to
clinical trial management for future trialists.
Discussion
A recurring theme in this paper is the need for those
planning and doing trials to have reliable and rapid
access to relevant expertise and for published standards
for trial management (conduct) that avoid trialists’ rein-
venting the wheel. Trial managers have, in recent years,
begun to develop better ways of disseminating and shar-
ing experiences and expertise. Societies and associations
of trial managers in North America and Europe are
beginning to network and make their knowledge available
via the Internet and through journal publications. The
acknowledgment by the UK Medical Research Council in
setting up the UK Trial Managers’ Network in 1998 high-
lighted the need to share expertise in this field and to
bring together trial managers who have no professional
forum in which to network. Experienced trialists will
have put together, either formally or informally, plans
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trial on the basis of their experience of what does or does
not work. Those planning their first trial often have to
start from scratch unless they are lucky enough to have
access to a clinical trials unit or someone with relevant
experience. Many trials struggle to finish, or even to get
underway, because the people running them have not
been able to find information about the best processes
for establishing and delivering a trial. There is a need for
appropriate training which is easily accessible, but the
real problem is the lack of a standard method which will
ensure high-quality trial management. Having such a
standard would ensure that both funders and trial man-
agers maximise the trial investment and the chances of
success. Much of trial management is intuitive utilisation
of skills gained in other areas of work or on the basis of
experience and as such could not be the subject of robust
research methodologies. Robust, meaningful and enforce-
able standards for the management of trials would
require effort on behalf of a collaborative group (using
trial management principles), including funders, investi-
gators, trial managers and other interested groups and
would take time but would do much to move the issue
forward. If such a standard could be agreed on, this
would more accurately identify training requirements
and open the door to more appropriate research into
what is undoubtedly a vital component in successfully
completing a clinical trial.
Conclusion
The very important and internationally accepted CON-
SORT Guidelines were developed because there was a
will to improve the way important research was pub-
lished. There is the same will amongst trialists to
improve trial management methods and provide sound
published evidence to be used to successfully evaluate
important health research. We urge that funders, trial-
ists, trial managers and all interested groups come
together, led by opinion leaders in the field, to discuss
and debate trial management methods with the aim of
providing a standard for trial management and a guide-
line for those running clinical trials to work toward. We
also suggest that the editors of medical journals might
want to consider the importance of how good research
is actually carried out and require that trial management
methods be part of articles considered for publication. If
trial management continues to be unrecognised through
a lack of standard methodology and training, it will be
to the detriment of future research and health care.
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